The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
Open accessAbstract
Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that occurs upon mutation of either the TSC1 or TSC2 genes, which encode the protein products hamartin and tuberin, respectively. Here, we show that hamartin and tuberin function together to inhibit mammalian target of rapamycin (mTOR)-mediated signaling to eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). First, coexpression of hamartin and tuberin repressed phosphorylation of 4E-BP1, resulting in increased association of 4E-BP1 with eIF4E; importantly, a mutant of TSC2 derived from TSC patients was defective in repressing phosphorylation of 4E-BP1. Second, the activity of S6K1 was repressed by coexpression of hamartin and tuberin, but the activity of rapamycin-resistant mutants of S6K1 were not affected, implicating mTOR in the TSC-mediated inhibitory effect on S6K1. Third, hamartin and tuberin blocked the ability of amino acids to activate S6K1 within nutrient-deprived cells, a process that is dependent on mTOR. These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mTOR and suggest that the formation of tumors within TSC patients may result from aberrantly high levels of mTOR-mediated signaling to downstream targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of the TSC1–TSC2 protein complex leads to hyperactivation of mTOR complex 1 (mTORC1)18, a key signalling node that regulates cellular anabolic and catabolic processes19.”
From mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis (2026) · cites this paper as [18]
In the citing paper
“The integration of the majority of external and survival signals feeding into the (m)TORC1 pathway occurs through the TSC complex (TSCC), composed of tuberous sclerosis complex protein 1 (TSC1) and TSC2, also known as hamartin and tuberin, and TBC1D7, which is the key signal integrator and negative regulator upstream of Rheb.”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Tee et al., 2002
In the citing paper
“This identification of this regulatory mechanism, shown using the human proteins, unequivocally identified TSC1-TSC2 as inhibitors of the mTORC1 signaling pathway (Inoki et al., 2002; Tee et al., 2002), specifically by virtue of TSC2 GAP activity toward the small GTPase Rheb (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003; Saucedo et al., 2003;”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Tee et al., 2002
Citations
Cites
TOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,914
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Self-citationRegulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., BELHAM, C. M., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,370
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151
Self-citationMammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Self-citationMalignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 971
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Kwiatkowski, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.525 · Cited by 674
Self-citationThe mRNA 5′ cap-binding protein eIF4E and control of cell growth
Sonenberg, N., & Gingras, A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80150-6 · Cited by 673
Flagged first, then by citations
Research works printed but not linked: 4
- E R Gomez, J R Sampson, V H Whittemore Developmental Perspectives in Psychiatry (Oxford Univ. Press, Oxford, 1999).
- T L Plank, R S Yeung, E P Henske Cancer Res 58, 4766–4770 (1998).
- Martin K. A. & Blenis J. (2002) Adv. Cancer Res. 86 in press.
- D Rousseau, A C Gingras, A Pause, N Sonenberg Oncogene 13, 2415–2420 (1996).
Cited by
Sorted by citations
Items 601–700 of 828
FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2
Tsutsumi, K., Nohara, A., Tanaka, T., Murano, M., Miyagaki, Y., & Ohta, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-47892-1 · Cited by 8
Clinical response to everolimus in a patient with Hodgkin’s lymphoma harboring a TSC2 mutation
Perini, G. F., Campregher, P. V., Ross, J. S., Ali, S. M., Hamerschlak, N., & Santos, F. P. S. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.25 · Cited by 8
Finding new edges: systems approaches to MTOR signaling
Heberle, A. M., Rehbein, U., Rodríguez-Peiris, M., & Thedieck, K. (2021) · Biochemical Society Transactions · doi:10.1042/bst20190730 · Cited by 8
Airway Smooth Muscle Growth in Asthma
Bentley, J. K., & Hershenson, M. B. (2012) · Proceedings of the American Thoracic Society · Cited by 8
Tolliver, S., Smith, Z. I., & Silverberg, N. B. (2022) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2022.02.010 · Cited by 8
Li, D., Zhao, K., Yang, X., Xiao, X., & Tang, S. (2017) · Molecules · doi:10.3390/molecules22040595 · Cited by 8
CFTR represses a PDX1 axis to govern pancreatic ductal cell fate
Rotti, P. G., Yi, Y., Gasser, G. N., Yuan, F., Sun, X., Evans, I. A., Wu, P., Liu, G., Choi, S. H., Reeves, R. E., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111393 · Cited by 7
The Spectrum of Renal “TFEopathies”: Flipping the mTOR Switch in Renal Tumorigenesis
Alesi, N., Asrani, K. V., Lotan, T. L., & Henske, E. P. (2024) · Physiology · doi:10.1152/physiol.00026.2024 · Cited by 7
(2010) · The Enzymes · doi:10.1016/s1874-6047(10)28002-2 · Cited by 8
Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis
Luo, H., Liao, X. P., Qin, Y., Hou, Q., Xue, Z., Liu, Y., Shen, F., Wang, Y., Jiang, Y., Song, L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.620924 · Cited by 7
Molecular Pathogenesis of Focal Cortical Dysplasia and Hemimegalencephaly
Crino, P. B. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190031101 · Cited by 7
Phacomatoses et tumeurs génétiquement déterminées : la transition enfant–adulte
de Ribaupierre, S., Vernet, O., Vinchon, M., & Rilliet, B. (2008) · Neurochirurgie · doi:10.1016/j.neuchi.2008.07.004 · Cited by 7
Familial Nervous System Tumor Syndromes
Strowd, R. E., III, & Plotkin, S. R. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000950 · Cited by 7
Chan, P. K. J., Back, S. J., Vatsky, S., Calle‐Toro, J. S., Khrichenko, D., Sridharan, A. N., Poznick, L., & Andronikou, S. (2021) · Pediatric Nephrology · doi:10.1007/s00467-020-04835-6 · Cited by 7
N-terminal hamartin-binding and C-terminal GAP domain of tuberin can separate in vivo
Momose, S., Kobayashi, T., Tada, N., Itoyama, S., & Hino, O. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.036 · Cited by 7
When Overgrowth Bumps Into Cancer: The PTEN-Opathies
Mester, J. L., & Eng, C. (2013) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/j.1552-4876.2013.31364.x · Cited by 7
The History of Tuberous Sclerosis Complex
Whittemore, V. (2010) · doi:10.1002/9783527630073.ch1 · Cited by 7
Taveira‐DaSilva, A. M., & Moss, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11475-8 · Cited by 7
mTORC1 activation drives astrocyte reactivity in cortical tubers and brain organoid models of TSCPreprint
Li, T. L., Blair, J. D., Yoo, T., Grant, G. A., Hockemeyer, D. F., Porter, B. E., & Bateup, H. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.28.640914 · Cited by 8
The dual role of the TSC complex in cancer
Hartung, J., Müller, C., & Calkhoven, C. F. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.10.009 · Cited by 8
Molecular Mechanisms Linking Adiponectin Receptor Signalling and Cancer
Nakajima, A., Endo, H., Yoneda, K., Fujisawa, T., Sugiyama, M., Hosono, K., Nozaki, Y., Takahashi, H., Fujita, K., Yoneda, M., et al. (2010) · The Open Obesity Journal · doi:10.2174/1876823701002010043 · Cited by 6
Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling
Nikesitch, N., Beraldi, E., Zhang, F., Adomat, H. H., Bell, R. H., Suzuki, K., Fazli, L., Kung, S. H. Y., Wells, C. A., Pinette, N. C., et al. (2023) · Oncogene · doi:10.1038/s41388-022-02573-7 · Cited by 6
Xu, H., Zhao, Y., Zhao, Q., Shi, M., Zhang, Z., Ding, W., & Zhao, Y. X. (2022) · Aging and Disease · doi:10.14336/ad.2022.0408 · Cited by 6
McCann, H. D., Johnson, C. E., Errington, R. J., Davies, D. M., Dunlop, E. A., & Tee, A. R. (2018) · Cancers · doi:10.3390/cancers10100375 · Cited by 6
Self-citationQiu, C., Li, C., Tong, X., Dai, L., Liu, W., Xie, Y., Zhang, Q., Yang, G., & Li, T. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1410 · Cited by 6
An integrated clinical approach to diffuse cystic lung diseases.
Harari, S. A., & Paciocco, G. (2005) · PubMed · Cited by 6
DiMario, F. J. (2019) · Wiley eBooks · doi:10.1002/9781119142812.ch143 · Cited by 6
Brown, S. P., Jena, A. K., Osko, J. J., & Ransdell, J. L. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106856 · Cited by 6
Dementieva, N. V., Nikitkina, E., Shcherbakov, Y. S., Плешанов, Н. В., Ryabova, A. E., Azovtseva, A. I., Silyukova, Y., Musidray, A., Griffin, D. K., & Romanov, M. N. (2025) · Frontiers in Bioscience-Scholar · doi:10.31083/fbs26022 · Cited by 5
The spectrum of nephrocutaneous diseases and associations
Wofford, J., Fenves, A. Z., Jackson, J. M., Kimball, A. B., & Menter, A. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.039 · Cited by 5
Spine morphogenesis and synapse formation in tubular sclerosis complex models
Shimada, T., & Yamagata, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019343 · Cited by 7
Vujovic, F., Shepherd, C. E., Witting, P. K., Hunter, N., & Farahani, R. H. (2023) · Antioxidants · doi:10.3390/antiox12101873 · Cited by 5
Role of Mammalian Target of Rapamycin (mTOR) in Muscle Growth
Panzhinskiy, E., Culver, B. W., Ren, J. T., Bagchi, D., & Nair, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396454-0.00022-9 · Cited by 5
THOMAS, M. P., Mills, J., & Engelbrecht, A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.008 · Cited by 5
Gayakwad, S., Shirolkar, A. R., Warkad, S. D., Bharsakale, S., Gaidhani, S. N., & Pawar, S. D. (2020) · Journal of Proteins and Proteomics · doi:10.1007/s42485-020-00031-0 · Cited by 5
Tarasewicz, A., Dębska-Ślizień, A. M., Rutkowska, B., Szurowska, E., & Matuszewski, M. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.03.028 · Cited by 5
Ben‐Ami, E., Hornick, J. L., & Wagner, A. J. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1493376 · Cited by 5
Neuro-Ophthalmologic Manifestations of Systemic and Intracranial Disease
Brodsky, M. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-69069-8_11 · Cited by 5
Papel de la vía fosfatidilinositol 3 kinasa(PI3K/Akt) en humanos
Pinzón, C. E., Serrano, M. L., & Sanabria, M. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 5
New therapies for tuber-less sclerosis
Ess, K. C., & Roach, E. S. (2012) · Neurology · doi:10.1212/wnl.0b013e318248a232 · Cited by 5
Magaki, S., & Vinters, H. V. (2018) · doi:10.1002/9781119013112.ch11 · Cited by 5
Shen, N.-X., Zhuo, Z., Luo, X., Li, B., Lin, X., Luo, S., Ye, Z.-L., Wang, P., He, N., Shi, Y., et al. (2024) · Acta Epileptologica · doi:10.1186/s42494-024-00189-w · Cited by 4
Protein Translation in Parkinson’s Disease
Kim, J. W., Abalde-Atristain, L., Jia, H., Martin, I., Dawson, T. M., & Dawson, V. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00009-2 · Cited by 4
Montesinos‐Cruz, V., Parra-Forero, L. Y., & Contreras, A. D. C. G. (2023) · Frontiers in Animal Science · doi:10.3389/fanim.2023.1275290 · Cited by 4
Insights into Tuberous Sclerosis Complex : From Genes to Clinics
Kim, S. Y. (2025) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2025.0035 · Cited by 4
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex
Gialloreti, L. E., Moavero, R., Marciano, S., Pardini, M., Benassi, F., Mutolo, M. G., & Curatolo, P. (2015) · Child s Nervous System · doi:10.1007/s00381-015-2702-x · Cited by 4
Pillon, A., Dare-Shih, J., Fong, J., da Silva, E. F., & Porter, L. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272741 · Cited by 4
Lee, B., Shin, C., Shin, M., Choi, B., Yuan, C., & Cho, K. S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.135 · Cited by 4
Partial dissociation of TSC2 and mTOR phosphorylation in cardiac and skeletal muscle of rats in vivo
Forsyth, S., & Vary, T. C. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9887-1 · Cited by 4
Tuberous Sclerosis Complex: Future Research Directions
Maria, B. L. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190090101 · Cited by 4
Tuberous Sclerosis Complex: mutations, functions and phenotypes
Sancak, Ő. (2005) · RePub (Erasmus University Rotterdam) · Cited by 4
Neurogenetics and the molecular biology of human brain tumors
Radovanovic, I., & Guha, A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-443-06967-3.00005-3 · Cited by 4
Mora-Molina, R., Yousfi, Y. E., Hagenlocher, C., Fernández-Farrán, F. J., Rehm, M., Palacios, C., Christophorou, M. A., & López‐Rivas, A. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08648-7 · Cited by 3
A fistful of iron: ferritin as a vulnerability point of the brain cancers
Segui, F., Parks, S. K., Vučetić, M., & Picco, V. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08564-w · Cited by 3
Rito, M., & Cabrera, R. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.11.011 · Cited by 3
Cheng, T. D., Fu, D. A., Falzarano, S. M., Zhang, R., Datta, S., Zhang, W., Omilian, A. R., Aduse‐Poku, L., Bian, J., Irianto, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413428 · Cited by 3
New Innovations: Therapies for Genetic Conditions
Rajabi, F., & Picker, J. D. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0043-9 · Cited by 4
Tuberous sclerosis and its rare association with macrodactyly and fibrous hamartomas
Lim, Y. S. E., Mak, M. S., & Mohan, P. C. (2017) · Skeletal Radiology · doi:10.1007/s00256-017-2683-9 · Cited by 3
Role of Mammalian Target of Rapamycin in Muscle Growth
Panzhinskiy, E., Culver, B. W., Ren, J. T., Bagchi, D., & Nair, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813922-6.00022-9 · Cited by 3
Siłuszyk, A., Maryniak, A., & Jóźwiak, S. (2018) · Child Neurology · doi:10.20966/chn.2018.54.421 · Cited by 3
Leucyl-tRNA synthetase 1 is required for proliferation of TSC-null cells
Bae, J.-H., & Kim, J. H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.080 · Cited by 3
Insulin signaling and pharmacology in humans and in corals
Murthy, M. H. S., Jasbi, P., Lowe, W., Kumar, L., Olaosebikan, M., Roger, L. M., Yang, J., Lewinski, N. A., Daniels, N. M., Cowen, L., et al. (2024) · PeerJ · doi:10.7717/peerj.16804 · Cited by 3
Tettoni, S. D., Egri, S. B., Doxsey, D. D., Veinotte, K., Ouch, C., Chang, J.-Y., Song, K., Chen, X., & Shen, K. (2023) · Structure · doi:10.1016/j.str.2023.06.012 · Cited by 3
The mTOR Pathway and Its Inhibitors
Easton, J. B., & Houghton, P. J. (2007) · Humana Press eBooks · doi:10.1385/1-59259-893-5:553 · Cited by 3
Signaling Pathways Induced by G-protein-coupled Receptors
Rozengurt, E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00004-x · Cited by 3
Juvenile cataract in association with tuberous sclerosis complex
Geffrey, A. L., Geenen, K. R., Abati, E., Greenstein, S. H., VanderVeen, D. K., Levy, R. L., Davidson, S. L., McGarrey, M. P., Thiele, E. A., & Aronow, M. E. (2020) · Ophthalmic Genetics · doi:10.1080/13816810.2020.1755989 · Cited by 3
The Mechanisms of Insulin Action
White, M. F., Copps, K. D., Özcan, U., & Tseng, Y. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00034-4 · Cited by 3
Primary TSC2-/meth Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
Bernardelli, C., Chiaramonte, E., Ancona, S., Sirchia, S. M., Cerri, A., & Lesma, E. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179713 · Cited by 3
Hwang, S.-H., Bang, S., Kim, W., & Chung, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011596 · Cited by 3
Chotechuang, N. (2010) · HAL · Cited by 3
EDITORIAL: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products
Huang, S. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990085 · Cited by 3
Wang, Y., Liao, Y., Sun, Y., Mitra, B., Guo, R., Piedras, B. I., White, S., Tang, H.-Y., Asara, J. M., Tempera, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65760-6 · Cited by 7
Models and Mechanisms of High-Fat Diet (HFD) Promotion of Pancreatic Cancer
Chang, H.-H., Eibl, G., & Rozengurt, E. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_10 · Cited by 2
LysM-positive neurons drive Tuberous Sclerosis Complex (TSC)-associated brain lesions
Zhang, J., Xu, S., Liang, K., Cao, X., Ye, Z., Huang, W., Bai, X., & Zhang, Y. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110468 · Cited by 2
Lin, J., Zhai, M., Qian, M., Li, Y., Han, M., Wang, K., Huang, W., Nan, G., & Jiang, J. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01701-w · Cited by 2
An Insight of Scientific Developments in TSC for Better Therapeutic Strategy
Natarajan, N., & Thiruvenkatam, V. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200825170355 · Cited by 2
Generation and Characterization of Monoclonal Antibodies Against Tuberous Sclerosis Complex 2
Malanchuk, O., Palchevskyy, S. S., Ovcharenko, G. V., Gwalter, J., Позур, В. К., Gout, I. T., & Filonenko, V. V. (2007) · Hybridoma · doi:10.1089/hyb.2007.0503 · Cited by 2
Papel de la vía fosfatidilinositol 3 kinasa(PI3K/Akt) en humanos
Pinzón, C. E., Serrano, M. L., & Sanabria, M. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 7
Ancona, E. C. S. (2014) · Journal of Cytology & Histology · doi:10.4172/2157-7099.s4-007 · Cited by 2
The Potential Impact of Maternal Milk Consumption During Pregnancy on mTORC1-Driven Fetal Growth
Melnik, B. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-14874-8_18 · Cited by 2
Genetic analysis of 18 families with tuberous sclerosis complex
Yin, K., Lin, N., Lu, Q., Jin, L., Huang, Y., Zhou, X., Xu, K., Liu, Q., & Zhang, X. (2022) · Neurogenetics · doi:10.1007/s10048-022-00694-5 · Cited by 2
Exosome Release by Glucose Deprivation Is Important for the Viability of TSC-Null Cells
Bae, J.-H., & Kim, J. H. (2022) · Cells · doi:10.3390/cells11182862 · Cited by 2
Kuroda, K., Moriya, K., Nakano, T., Saito, R., Sato, D., Katayama, S., Niizuma, H., Watanuki, M., Uematsu, M., Sasahara, Y., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.28960 · Cited by 2
COVID 19 in a family with rare genetic disease of the nervous system
Martynov, M. Y., Куташов, В. А., & Ulyanova, O. V. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-1-108-114 · Cited by 2
The Role of Target of Rapamycin Signaling in Tuberous Sclerosis Complex
Manning, B. D. (2010) · Wiley eBooks · doi:10.1002/9783527630073.ch6 · Cited by 2
Self-citationMutational and functional study of Tuberous Sclerosis Complex 1 and 2 genes (TSC1 and TSC2)
de Almeida, L. G. D. (2019) · doi:10.11606/t.41.2019.tde-27082019-100610 · Cited by 2
The Regulation of Mammalian Target of Rapamycin
Xie, J. (2012) · Figshare · Cited by 2
mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis
Li, T. L., Blair, J. D., Yoo, T., Grant, G. A., Hockemeyer, D., Porter, B. E., & Bateup, H. S. (2026) · Nature · doi:10.1038/s41586-026-11054-w · Cited by 1
Lee, C. S., Lee, S. C., & Singh, A. D. (2013) · Springer eBooks · doi:10.1007/978-3-642-39489-8_4 · Cited by 1
Exploring the uncharted role of cell senescence in rare diseases
Selvaggio, P., Taci, E., Barassi, A., Massa, V., Gervasini, C., Lesma, E. A., Bernardelli, C., & Fede, E. D. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03778-1 · Cited by 1
Ikeda, T., Hong, S., Yoshida, S., Srivastava, S. P., Kunamneni, A., Yao, Y., Khuperkar, O., Basrur, V., Kuang, H., Kachman, M. T., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116382 · Cited by 1
Tuberöse Sklerose-Komplex: Präzisionstherapie mit mTOR-Inhibitoren
Franz, D. N., Eckeberg, W. C., & Ritter, D. M. (2026) · Clinical Epileptology · doi:10.1007/s10309-026-00829-w · Cited by 1
2 Nutrient sensing in animal cells and integration of nutrient and endocrine signalling pathways
Proud, C. G., Hundal, H. S., & Taylor, P. M. (2004) · Topics in current genetics · doi:10.1007/978-3-540-39898-1_3 · Cited by 1
mTORC1: A Signaling Integration Node Involved in Cell Growth
Kubica, N., & Blenis, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_1 · Cited by 1
Self-citationCharacteristic expression of p57/ K ip2 in balloon cells in focal cortical dysplasia
Kimura, T., Kitaura, H., Masuda, H., Kameyama, S., Saito, Y., Sugai, K., Otsuki, T., Nakazawa, A., Morota, N., Yamamoto, T., et al. (2015) · Neuropathology · doi:10.1111/neup.12199 · Cited by 1
The management of tuberous sclerosis
Osborne, J. P., & O'Callaghan, F. J. (2003) · Current Paediatrics · doi:10.1016/s0957-5839(03)00078-2 · Cited by 1
Familial Tumors (Neurocutaneous Syndromes)
Dorward, I. G., & Leonard, J. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00208-2 · Cited by 1
Management of Subependymal Giant Cell Astrocytomas in Patients with Tuberous Sclerosis
조민수, 김정아, 이준수, kim, D. S., 강훈철, & Kim, H. D. (2015) · Annals of Child Neurology · doi:10.26815/jkcns.2015.23.1.1 · Cited by 1
Chromophobe Renal Cell Carcinoma
Lim, A. R., & Rathmell, W. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-96989-3_4 · Cited by 1
DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines
Yihong, S., Tang, X., Ye, B., & Ding, K. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s318724 · Cited by 1
Metadata
- Authors
- Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Blenis, John
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-09-23
- Volume
- 99
- Issue
- 21
- Pages
- 13571-13576
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129715
- OpenAlex
- W2087812126
- Cited by
- 827
- References
- 31
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 17 · 2023: 27 · 2022: 29 · 2021: 35 · 2020: 40 · 2019: 22 · 2018: 37 · 2017: 35 · 2016: 31 · 2015: 45 · 2014: 28 · 2013: 43 · 2012: 42
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-08-09)
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM 41890, GM51405, R01GM056203, GM 56203, R01GM051405, R01GM041890, R37GM041890)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- tuberous sclerosis complex, TSC1, TSC2, hamartin, tuberin, mTOR signaling, 4E-BP1, S6K1, amino acid signaling, nutrient deprivation, rapamycin resistance, protein phosphorylation, eIF4E, tumor formation
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Amino Acids, Carrier Proteins, Cell Line, Humans, Insulin, Models, Biological, Phosphoproteins, Phosphorylation, Protein Kinases, Proteins, Repressor Proteins, Tuberous Sclerosis, Signal Transduction, Point Mutation, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, TOR Serine-Threonine Kinases, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
